The AZEK Company Statistics
Total Valuation
PT Suparma Tbk has a market cap or net worth of IDR 870.53 billion. The enterprise value is 1.37 trillion.
Market Cap | 870.53B |
Enterprise Value | 1.37T |
Important Dates
The last earnings date was Monday, July 28, 2025.
Earnings Date | Jul 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PT Suparma Tbk has 3.15 billion shares outstanding.
Current Share Class | 3.15B |
Shares Outstanding | 3.15B |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 81.58% |
Owned by Institutions (%) | 0.02% |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 7.99.
PE Ratio | 7.99 |
Forward PE | n/a |
PS Ratio | 0.32 |
PB Ratio | 0.36 |
P/TBV Ratio | 0.36 |
P/FCF Ratio | 1.48 |
P/OCF Ratio | 1.41 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.99, with an EV/FCF ratio of 2.34.
EV / Earnings | 12.61 |
EV / Sales | 0.50 |
EV / EBITDA | 4.99 |
EV / EBIT | 8.84 |
EV / FCF | 2.34 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.27.
Current Ratio | 2.37 |
Quick Ratio | 0.59 |
Debt / Equity | 0.27 |
Debt / EBITDA | 2.43 |
Debt / FCF | 1.14 |
Interest Coverage | 4.67 |
Financial Efficiency
Return on equity (ROE) is 4.53% and return on invested capital (ROIC) is 3.17%.
Return on Equity (ROE) | 4.53% |
Return on Assets (ROA) | 2.81% |
Return on Invested Capital (ROIC) | 3.17% |
Return on Capital Employed (ROCE) | 5.38% |
Revenue Per Employee | 3.33B |
Profits Per Employee | 132.15M |
Employee Count | 808 |
Asset Turnover | 0.79 |
Inventory Turnover | 2.41 |
Taxes
In the past 12 months, PT Suparma Tbk has paid 30.81 billion in taxes.
Income Tax | 30.81B |
Effective Tax Rate | 22.06% |
Stock Price Statistics
The stock price has decreased by -6.67% in the last 52 weeks. The beta is 0.57, so PT Suparma Tbk's price volatility has been lower than the market average.
Beta (5Y) | 0.57 |
52-Week Price Change | -6.67% |
50-Day Moving Average | 264.64 |
200-Day Moving Average | 283.71 |
Relative Strength Index (RSI) | 63.39 |
Average Volume (20 Days) | 380,925 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Suparma Tbk had revenue of IDR 2.74 trillion and earned 108.89 billion in profits. Earnings per share was 34.52.
Revenue | 2.74T |
Gross Profit | 382.07B |
Operating Income | 155.36B |
Pretax Income | 139.71B |
Net Income | 108.89B |
EBITDA | 269.49B |
EBIT | 155.36B |
Earnings Per Share (EPS) | 34.52 |
Balance Sheet
The company has 165.45 billion in cash and 668.53 billion in debt, giving a net cash position of -503.07 billion or -159.50 per share.
Cash & Cash Equivalents | 165.45B |
Total Debt | 668.53B |
Net Cash | -503.07B |
Net Cash Per Share | -159.50 |
Equity (Book Value) | 2.44T |
Book Value Per Share | 772.88 |
Working Capital | 848.19B |
Cash Flow
In the last 12 months, operating cash flow was 618.34 billion and capital expenditures -30.51 billion, giving a free cash flow of 587.83 billion.
Operating Cash Flow | 618.34B |
Capital Expenditures | -30.51B |
Free Cash Flow | 587.83B |
FCF Per Share | 186.37 |
Margins
Gross margin is 13.93%, with operating and profit margins of 5.67% and 3.97%.
Gross Margin | 13.93% |
Operating Margin | 5.67% |
Pretax Margin | 5.09% |
Profit Margin | 3.97% |
EBITDA Margin | 9.83% |
EBIT Margin | 5.67% |
FCF Margin | 21.44% |
Dividends & Yields
This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 4.35%.
Dividend Per Share | 12.00 |
Dividend Yield | 4.35% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 4 |
Payout Ratio | 34.68% |
Buyback Yield | n/a |
Shareholder Yield | 4.41% |
Earnings Yield | 12.51% |
FCF Yield | 67.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on June 15, 2022. It was a forward split with a ratio of 1.13.
Last Split Date | Jun 15, 2022 |
Split Type | Forward |
Split Ratio | 1.13 |
Scores
PT Suparma Tbk has an Altman Z-Score of 2.2 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.2 |
Piotroski F-Score | 6 |